Amalgamated Bank Biotechnology

Amalgamated Bank

$12.1 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CRDF Cardiff Oncology, Inc.	$146M	$4,000 0.0% of portfolio	1,355	Q2 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$69.3M	$4,000 0.0% of portfolio	1,451	Q2 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$97.2M	$4,000 0.0% of portfolio	2,080	Q1 2024 Reduced 66.67%
BLUE Bluebird Bio, Inc.	$639M	$3,000 0.0% of portfolio	6,510	Q1 2024 Reduced 27.82%
FENC Fennec Pharmaceuticals Inc.	$149M	$3,000 0.0% of portfolio	612	Q1 2024 Reduced 66.67%
KOD Kodiak Sciences Inc.	$470M	$3,000 0.0% of portfolio	1,154	Q1 2024 Reduced 60.07%
XFOR X4 Pharmaceuticals, Inc	$30.9M	$3,000 0.0% of portfolio	4,152	Q1 2024 Reduced 70.52%
GLSI Greenwich Life Sciences, Inc.	$160M	$3,000 0.0% of portfolio	207	Q2 2024 New
ADGI Adagio Therapeutics, Inc.	$505M	$3,000 0.0% of portfolio	2,744	Q2 2024 New
TNYA Tenaya Therapeutics, Inc.	$60.8M	$3,000 0.0% of portfolio	1,587	Q2 2024 Added 62.1%
VTYX Ventyx Biosciences, Inc.	$111M	$3,000 0.0% of portfolio	1,594	Q1 2024 Reduced 76.0%
QSI Quantum Si Inc	$281M	$3,000 0.0% of portfolio	3,170	Q1 2024 Reduced 62.74%
PEPG Pep Gen Inc.	$57.2M	$3,000 0.0% of portfolio	337	Q1 2024 Reduced 72.22%
RGLS Regulus Therapeutics Inc.	$18.6M	$3,000 0.0% of portfolio	2,185	Q2 2024 New
GALT Galectin Therapeutics Inc	$76.1M	$2,000 0.0% of portfolio	705	Q2 2024 New
OVID Ovid Therapeutics Inc.	$52.8M	$2,000 0.0% of portfolio	2,011	Q1 2024 Reduced 61.34%
RAPT Rapt Therapeutics, Inc.	$35.6M	$2,000 0.0% of portfolio	910	Q1 2024 Reduced 75.43%
ALXO Alx Oncology Holdings Inc	$66.4M	$2,000 0.0% of portfolio	897	Q1 2024 Reduced 52.06%
HOWL Werewolf Therapeutics, Inc.	$39.6M	$2,000 0.0% of portfolio	1,055	Q2 2024 New
HLVX Hille Vax, Inc.	$63.2M	$2,000 0.0% of portfolio	891	Q1 2024 Reduced 55.45%
ATNM Actinium Pharmaceuticals, Inc.	$30.5M	$2,000 0.0% of portfolio	877	Q1 2024 Reduced 75.69%
INMB Inmune Bio, Inc.	$117M	$2,000 0.0% of portfolio	422	Q2 2024 New
VRCA Verrica Pharmaceuticals Inc.	$327M	$1,000 0.0% of portfolio	704	Q1 2024 Reduced 76.18%
ENOB Enochian Biosciences Inc	$244M	$1,000 0.0% of portfolio	1,687	Q2 2024 New
PRLD Prelude Therapeutics Inc	$37.5M	$1,000 0.0% of portfolio	334	Q1 2024 Reduced 61.34%
AVTE Aerovate Therapeutics, Inc.	$60.4M	$1,000 0.0% of portfolio	347	Q1 2024 Reduced 75.77%
ELYM Eliem Therapeutics, Inc.	$109M	$1,000 0.0% of portfolio	252	Q2 2024 New
IPSC Century Therapeutics, Inc.	$55.3M	$1,000 0.0% of portfolio	706	Q1 2024 Reduced 62.51%
ELEV Elevation Oncology, Inc.	$16.3M	$1,000 0.0% of portfolio	1,805	Q2 2024 New
LYRA Lyra Therapeutics, Inc.	$6.05M	$0 0.0% of portfolio	1,674	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.